# SMIM31

## Overview
SMIM31 is a gene that encodes the small integral membrane protein 31, which is categorized as a transmembrane protein. This gene has garnered attention due to its involvement in various cellular processes, particularly in the context of cancer biology. The protein product of SMIM31 is implicated in the regulation of cell proliferation and maintenance of stemness characteristics, which are critical in oncogenesis. Research has demonstrated that SMIM31 functions as an oncogene in certain cancers, such as head and neck squamous cell carcinoma, by modulating gene expression through competitive endogenous RNA mechanisms (Chen2020FOXA1induced). Additionally, SMIM31 has been associated with other malignancies, including lung adenocarcinoma and colorectal adenocarcinoma, where it contributes to cancer cell survival and proliferation (Chen2020FOXA1induced; Jiang2020Knowledgebased). Its potential role in hepatitis B virus-related hepatocellular carcinoma further underscores the gene's significance in cancer research and its potential as a therapeutic target (Jiang2020Knowledgebased).

## Clinical Significance
SMIM31, also known as LINC01207, has been implicated in several cancers due to its role in promoting cell proliferation and maintaining stemness characteristics. In head and neck squamous cell carcinoma (HNSCC), SMIM31 acts as an oncogene by functioning through a competitive endogenous RNA mechanism, where it sponges miR-5047, leading to the upregulation of TNRC6B. This process is facilitated by FOXA1, which induces the transcription of both SMIM31 and TNRC6B, contributing to tumor growth in HNSCC (Chen2020FOXA1induced). 

SMIM31 is also associated with lung adenocarcinoma and colorectal adenocarcinoma, where it is linked to cancer cell proliferation and survival, suggesting its potential as a therapeutic target (Chen2020FOXA1induced; Jiang2020Knowledgebased). In the context of hepatitis B virus-related hepatocellular carcinoma (HCC), SMIM31 has been identified as a candidate gene with suggestive significance in gene-based association analyses, although further functional validation is required to confirm its role in HCC risk (Jiang2020Knowledgebased). These findings highlight the clinical significance of SMIM31 in various cancers, underscoring its potential as a biomarker and target for therapeutic intervention.


## References


[1. (Chen2020FOXA1induced) Chao Chen, Lin Jiang, Yan Zhang, and Weihui Zheng. Foxa1-induced linc01207 facilitates head and neck squamous cell carcinoma via up-regulation of tnrc6b. Biomedicine &amp; Pharmacotherapy, 128:110220, August 2020. URL: http://dx.doi.org/10.1016/j.biopha.2020.110220, doi:10.1016/j.biopha.2020.110220. This article has 15 citations.](https://doi.org/10.1016/j.biopha.2020.110220)

[2. (Jiang2020Knowledgebased) Deke Jiang, Jiaen Deng, Changzheng Dong, Xiaopin Ma, Qianyi Xiao, Bin Zhou, Chou Yang, Lin Wei, Carly Conran, S. Lilly Zheng, Irene Oi-lin Ng, Long Yu, Jianfeng Xu, Pak C. Sham, Xiaolong Qi, Jinlin Hou, Yuan Ji, Guangwen Cao, and Miaoxin Li. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis b virus related hepatocellular carcinoma. BMC Cancer, May 2020. URL: http://dx.doi.org/10.1186/s12885-020-06842-0, doi:10.1186/s12885-020-06842-0. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-020-06842-0)